ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

INTI Inet Technologies, (MM)

0.00
0.00 (0.00%)
Pre Market
Last Updated: -
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Company Name Stock Ticker Symbol Market Type
Inet Technologies, (MM) INTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% -
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 USD

Inet Technologies, (MM) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.12M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Inet News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No INTI Message Board. Create One! See More Posts on INTI Message Board See More Message Board Posts

Historical INTI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Inet Description

Inhibitor Therapeutics Inc, formerly HedgePath Pharmaceuticals Inc is a pharmaceutical development company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. The company's main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.

Your Recent History

Delayed Upgrade Clock